Adrenergic factors regulating cell division in the colonic crypt epithelium during carcinogenesis and in colonic adenoma and adenocarcinoma. by Kennedy, M. F. et al.
Br. J. Cancer (1985), 52, 383-390
Adrenergic factors regulating cell division in the colonic
crypt epithelium during carcinogenesis and in colonic
adenoma and adenocarcinoma
M.F.G. Kennedy, P.J.M. Tutton & D.H. Barkla
Department ofAnatomy, Monash University, Clayton, Victoria, Australia.
Summary Evidence exists implicating adrenergic factors in the control of intestinal epithelial cell
proliferation in both normal and diseased states. In this report, attention is focussed on changes in the amine
requirements of proliferating cells during the chemical induction of tumours in the colon of mouse. Cell
proliferation rates were measured stathmokinetically. Tumours were induced by s.c. injection of
dimethylhydrazine(DMH). Results with a series of adrenoceptor agonists and antagonists suggest that there is
an alpha2-adrenoceptor mediated excitatory effect in normal colon but an alpha2 adrenoceptor mediated
inhibitory effect in adenoma and carcinoma. Alpha1 adrenoceptors, on the other hand, have an inhibitory
effect in normal crypts and in adenomas, and an excitatory effect in carcinomas. Beta adrenoceptors have an
inhibitory effect in the normal and DMH-treated crypt, and in adenomas, but not in carcinomas. In the crypt
epithelium of DMH-treated mice, two regions on cell proliferation, with differing regulatory factors, could be
identified. In the upper region of the carcinogen-exposed crypt is a zone where cell proliferation is stimulated
by an alpha2 adrenergic mechanism, thus resembling the basal region of the normal crypt. By contrast, in the
basal region of these crypts, cell proliferation is stimulated by an alpha, mechanism, thus resembling a
malignant tumour.
During the last two decades a substantial body of
evidence has emerged implicating adrenergic factors
in the control of intestinal epithelial cell
proliferation in both normal and disordered states.
In essence, noradrenaline released from the
sympathetic nervous system appears to stimulate
crypt cell proliferation both in the small intestine
(Tutton & Helme, 1974) and in large intestine
(Tutton & Barkla, 1977): this effect is mediated by
an alpha adrenoceptor. Sympathectomy, on the
other hand, appears to inhibit crypt cell
proliferation (Dupont et al., 1965; Klein, 1979).
Adrenaline, by contrast, inhibits cell division in
both normal and neoplastic intestinal epithelial cells
and this effect is mediated by a beta adrenoceptor.
For a detailed review, see Tutton & Barkla (1983).
Recent advances in the understanding of adrenergic
mechanisms allow some of the earlier observations
on adrenergic regulation of cell division to now be
followed up in more detail. Kennedy et al. (1983)
showed that the adrenergic stimulation of intestinal
epithelial cell division involved a post-synaptic
alpha2 adrenoceptor and that localised interruption
of sympathetic nerves by cryosurgery produces a
similarly localised inhibition of cell division.
Stimulation of cell proliferation by an alpha2
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adrenergic mechanism has also been reported in
cultured hepatocytes (Michalopoulos et al., 1984).
The present report extends the findings of Kennedy
et al. (1983) to cover the effects of alpha,, alpha2,
and beta adrenergic agents on cell division in the
colon of mice during and after treatment with the
carcinogen, dimethylhydrazine (DMH).
Materials and methods
Male outbred Swiss mice, weighing 25-40g, were
fed Clark King GR2 pellets and received tap water
(with 0.1% HCI) ad libitum, and were housed in a
controlled environment at 21-24°C with artificial
light from 0800 to 1700h and darkness from 1700
to 0800h.
Induction ofmouse colonic tumours
Commencing at 4-6 weeks of age, mice were given
s.c. injections of 21 mg of DMH dihydrochloride
(Aldrich Chemical Co., Inc., Milwaukee, Wis.) per
kg for 15 weeks. The stock solution for injections
comprised 400mg of DMH dihydrochloride dis-
solved in 100ml of distilled water containing 37mg
of ethylene diamine tetracetic acid, and was
adjusted to pH 6.5 using sodium hydroxide. In
most cases, and unless specified to the contrary,
mice were used in the experiments described below
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3-months after the last injection. However one
group of mice was sacrificed one week after
completing the DMH treatment and another group
received only half the normal course of treatment
and were used one year later.
Estimation ofmitotic rates
To arrest cell division at metaphase, all animals
were injected with vinblastine sulphate (Velba, Eli
Lilly Co., lOmgkg-1i.p.) at 1200h and were
sacrificed by cervical dislocation 'at times ranging
from 0.75 to 4.0h later. Whilst this dose of vin-
blastine may seem high it was found to be the
lowest dose that provided reliable metaphase block
in the colonic crypts. For each estimate of mitotic
rate in the crypt epithelium at least 6 animals were
used. For estimates of mitotic rate in adenomas and
carcinomas initially 6 potentially tumour bearing
animals were injected with vinblastine and the
agent under investigation (i.e. amine agonist or
antagonist). Naturally it was found that some
animals contained more than one tumour of a
particular type (i.e. adenoma or carcinoma) whereas
others contained none. When more than one
tumour of a particular type was found the mitotic
index was estimated in each of them: when no
tumour of a particular type was found, another
animal was injected with vinblastine and the agent
in question at a later date. Thus all estimates were
based on results from at least 6 tumours. Specimen
tissues from tumours and from descending colon
were fixed in 10% Bouin's solution, dehydrated
through alcohols, embedded in paraffin, and
sectioned at 4pm.
The tissues were examined histologically and
surveyed for the presence of anaphase and telo-
phase mitotic figures, and when present all tissues
from that animal were excluded from the study and
that component of the study was repeated. Counts
of metaphase and non-metaphase cells in the crypts
were made at x 800 magnification as previously
described (Tutton & Barkla, 1976). Metaphase
indices were corrected for the geometric artifact
described originally by Tannock (1967). The
magnitude of Tannock's correction factor was
estimated using the method previously reported
(Kennedy et al., 1983). Counts of metaphase and
non-metaphase cells in colonic adenomas and
adenocarcinomas were made at 1250 x magnifi-
cation. Fifty longitudinally sectional crypts or at
least 25-high power fields of tumour were examined
per specimen. Mitotic activity in tumours was
assessed in high power fields located at the centre
of consecutive low power (125 x) fields along two
mutually perpendicular axes from edge to edge of
the section. When insufficient crypts or fields were
available per histological section, a subsequent
section or sections, separated by 100g,m from each
previously examined section was evaluated.
Graphs of corrected metaphase index (for colonic
crypts) and of observed metaphase index (for
colonic tumours) versus duration of vinblastine
treatment were then constructed for each
experimental group of tissues having mitoses
blocked for periods of 0.75-4.0h. The normal
control values were calculated from eleven periods
(0.75, 1.0, 1.25, 1.5, 2.0, 3.0, 3.25, 3.5, 3.75. 4.0h).
All other experimental results were calculated from
six representative periods. The method of least
squares was then used to estimate the regression
coefficient for each of the graphs. This calculated
value represents the rate of cell entry to metaphase
and is expressed in the units of mitoses cell-1 h. -1
Analysis of variance was then used to estimate the
statistical significance of apparent differences
between the values of the regression coefficient for
experimental groups of tissues.
Quintile studies in colon adjacent to tumours
In addition, in each of ten treatment groups, the
number of metaphase and non-metaphase nuclei
was recorded for each individual one-fifth of the
height of longitudinally sectioned crypts of
Lieberkuhn. Thus, for example, in a longitudinally
sectioned crypt with a total of 60 epithelial cell
nuclei on each side of the glandular lumen, the
number of metaphase figures included in the twelve
most basal cells on each side (i.e. in the lowest 24
cells) was recorded; corresponding counts were then
made for each group of 24 cells lying nearer to the
neck of the crypt. The metaphase index of each of
the five levels (quintiles) was then calculated for
each animal within the four hour period in which
metaphases had accumulated.
Chemical sympathectomy
In order to assess the role of the sympathetic
nervous system in the control of crypt cell and
tumour cell division, groups of mice were
chemically sympathectomized by i.v. administration
of 6-hydroxydopamine (6-OHDA) (Sigma Chemical
Co.), at a dose of 200mgkg-1 i.v. Between 6 and 8
days after 6-OHDA injection, mice were injected
with vinblastine and the mitotic rate was calculated,
as described above.
Alpha-adrenergic agents
In order to evaluate the influence of alpha-
adrenoceptor activity on crypt cell and tumour cell
proliferation, mice were injected with the nor-
adrenaline-mimicking agent, metaraminol (Merck,
Sharp and Dohme Ltd., 2.5mgkg- i.p.) at 1200h
(i.e. with the vinblastine injection) and again atADRENERGIC FACTORS AND COLONIC CARCINOGENESIS 385
1400h. Further groups of animals were injected
with the alpha-adrenergic antagonist, phentolamine
(Ciba Pharmaceuticals, 10mgkg-1 i.p.) at 1200h.
Four groups of mice for each tissue type were each
treated with a different selective alpha-adrenergic
agent to assess the subclass of alpha-adrenoceptor
involved in the regulation of proliferation. Prazosin
(Pfizer Ltd., 5mgkg-'i.p.) was used as an alpha1-
adrenoceptor antagonist, whilst phenylephrine
(Winthrop Laboratories, 3mgkg-1 i.p.) was used as
an alpha1 agonist. Yohimbine (Stigma Chemical
Co., l0mgkg- i.p.) was used as the alpha2-
antagonist, and clonidine (Boehringer Ingelheim,
20 igkg- I i.p.) was used as an alpha2-agonist.
LZ HZ1~ Control
.**L:3 * DMH + 1 week Crypt ** DMH + 4 months
*** 1/2 DMH + 1 year
Turnour *** Adenoma
Tumour _______________\ ***Carcinoma
0 0.01 0.02 0.03
Mitoses cell-1 h-1
Figure 1 Comparison of cell proliferation rates in
normal and abnormal colonic epithelial cells. For
details of DMH treatment see Materials and methods.
*** P<0.001 vs control.
Beta-adrenergic agents
Beta-adrenoceptor involvement was also
investigated using several adrenergic agents.
Adrenaline (Sigma Chemical Co., 1 mgkg-1i.p.),
an alpha- and beta-adrenoceptor agonist, was
injected at 1200h into four groups of animals. A
second dose was given to the surviving mice at
1400h. Isoprenaline (Winthrop Laboratories,
0.5mgkg-1, i.p.) was used as the beta-adrenergic
agonist and propranolol (ICI Ltd., 10mgkg-1) was
chosen as the beta-adrenoceptor antagonist.
Because isoprenaline is a potent noradrenaline re-
leasing agent (Rand et al., 1980), groups of
chemically sympathectomized mice were also
treated with isoprenaline.
Results
The influence ofDMH-treatment
In the colonic crypts of normal mice the mitotic
rate was 0.0066+0.0002 (mean+se) mitoses
cell - h-1, whilst one week after the end of DMH-
treatment it was elevated to 0.0142+0.0002
(P<0.001). Three months later, in the crypts of
tumour bearing mice it was still higher than in
control animals, at 0.0098 +0.0004 mitoses
cell-1h+' (P<0.005). In mice examined one year
after a shortened course of DMH, the mitotic rate
remained abnormally high by comparison with
untreated mice, a value of 0.0109+0.0003 mitoses
cell - h-1 being seen (P<0.005). In DMH-induced
colonic adenoma, the mitotic rate was 0.0191
+0.0005, and in DMH-induced colonic adeno-
carcinoma it was 0.0113 +0.0004 mitoses cell 1 h 1
These results are summarised in Figure 1. When
these results were analyzed separately for five levels
within the crypts it became clear that DMH
stimulated cell production most in the 1st, 3rd and
4th quintiles of the crypt and least in the 2nd
quintile where cell production is most normally
rapid (Figure 2).
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Figure 2 Comparison of cell proliferation rates in
colonic crypt epithelium before and after DMH treat-
ment; by quintiles; ** P<0.01 vs control; *** P<0.001
vs control.
The influence ofchemical sympathectomy
In the colonic crypts of sympathectomized, non-
DMH treated mice, the mitotic rate, 0.0048 +0.0002
mitoses cell-1 h-1, was significantly lower
(P<0.001) than in the crypts of Lieberkuhn in
control animals and in mice which had just finished
their DMH treatment sympathectomy still lowered
the mitotic rate to 0.0100+0.0002 mitoses
cell-l h- (P<0.001). However, in the colonic
crypts of mice three months after finishing the386 M.F.G. KENNEDY et al.
DMH treatment, in colonic adenomas and colonic
adenocarcinomas, the mitotic rate after 60HDA
was significantly faster than in non-
sympathectomized mice (Figure 3 and 4). Within
the colonic crypts of normal mice, chemical sym-
pathectomy had a statistically significant inhibitory
effect only in the third quintile whereas immediately
following DMH treatment the region where
chemical sympathectomy significantly inhibited cell
production had it expanded to include the 2nd, 4th
and 5th as well as the 3rd quintile. By contrast, in
mice that had completed their DMH treatment
three months earlier, chemical sympathectomy was
associated with accelerated cell production in the
2nd and 3rd quintiles of the crypt (cf. neoplasm)
and retarded cell production (cf. normal) in the 4th
and 5th quintiles (Figure 5).
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Figure 3 Influence of chemical sympathectomy
(60HDA) and various adrenergic agonists and
antagonists on cell proliferation rates in normal (El)
and carcinogen treated (0) colonic crypt epithelium
tt P<0.01 vs control; * P<0.05 vs same tissue without
adrenergic agent; ** <0.01 vs same tissue without
adrenergic agent; ***P<0.001 vs same tissue without
adrenergic agent.
The influence ofalpha-adrenergic agents
Stimulation of alpha-adrenoceptors by treatment
with metaraminol resulted in cell proliferation being
accelerated in the colonic crypts of normal mice.
(Figure 3). However it was significantly reduced in
the colonic crypts of DMH-treated mice and in
both adenomas and adenocarcinomas (Figure 4).
Blockade of alpha-adrenoceptors by phentolamine
led to a significant reduction of crypt cell mitotic
rate in normal and DMH-treated colon, an increase
in the mitotic rate of adenomas and no statistically
significant change in adenocarcinomas.
Treatment with the alpha2-adrenoceptor
antagonist yohimbine produced a reduction in crypt
cell mitotic rate in normal and DMH-treated colon
and an increase in the rate of cell proliferation in
adenoma and adenocarcinoma. Within the crypts of
normal animals the inhibitory effect of yohimbine
was seen across the lower four quintiles (See Figure
6). Immediately following DMH-treatment the
inhibitory effect of yohimbine extended from the
Control
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Phentolamine
H Yohimbine
,* Clonidine
* Prazosin
XZ "Z Ji*** Phenylephrine
** Adrenaline
Propranolol
ERZZ~ **
** Isoprenaline
EZZZZ~I4 ** Isoprenaline /60HDA
0 0.010 0.020 0.030
Mitoses cell-' h-1
Figure 4 Influence of chemical sympathectomy
(60HDA) and various adrenergic agonists and anta-
gonists on cell proliferation rates in colonic adenomas
(E]) and colonic carcinoma (c). tttP<0.001
between adenoma and carcinoma. *P<0.05 vs same
tissue without adrenergic agent; **P<0.01 vs same
tissue without adrenergic agent; ***P<0.001 vs same
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Figure 5 Influence of chemical sympathectomy
(60HDA) on cell proliferation rates in the colonic
crypt epithelium before and after DMH treatment; by
quintiles. ***P<0.001 vs tissue without 60HDA.
second to the fifth quintiles of the crypts, having no
significant effect on the lowermost quintile.
However, three months after the completion of the
DMH-treatment the inhibitory effect of yohimbine
was seen in the 1st, 4th and 5th quintile, but with a
trend towards yohimbine stimulating cell division in
the 2nd quintile. Treatment with the alpha2-
adrenoceptor agonist, clonidine, resulted in a
significant increase in the mitotis rate in non-DMH
treated colon, and in a significant reduction in
DMH-treated colon, adenoma and adenocarcinoma
(Figures 3 and 4).
Treatment with the alpha1-adrenoceptor agonist,
phenylephrine, significantly reduced the mitotic rate
in the colon of normal mice and in adenomas.
However, the same treatment was observed to
increase the mitotic rate in DMH-treated colon and
in adenocarcinomas. Treatment with the alpha1-
adrenoceptor antagonist, prazosin, produced
opposite effects in each of the 4 groups, i.e. it
accelerated cell production in the normal colon and
in adenomas but inhibited it in carcinogen-treated
0 0.01 0.02 0.03
Mitoses cell-' h-W
Figure 6 Influence of yohimbine treatment on cell
proliferation rates in the colonic crypt epithelium
before and after DMH treatment; by quintiles.
* P<0.05 vs same tissue without yohimbine;
**P<0.0l vs same tissue without yohimbine;
P P<0.001 vs same tissue without yohimbine.
colon and in carcinomas. Analysis of these
responses at various levels within the crypts of
DMH-treated mice revealed that alpha1-
adrenoceptor activity was stimulatory to cell
division in the base of the crypt and inhibitory in
the more superficial region (Figure 7).
The influence ofbeta adrenergic agents
Treatment with adrenaline produced a reduction in
crypt cell proliferation in the colon of normal mice,
but an increased mitotic rate in DMH-treated
colon, adenoma and adenocarcinoma. In colonic
crypts of normal and DMH-treated mice and in
adenomas, treatment with propranolol resulted in a
significant acceleration of mitotic rate. In
adenocarcinomas, the mitotic rate showed no
significant alteration following treatment with pro-
pranolol. In the colon of normal mice, administra-
tion of isoprenaline did not significantly alter the
rate of cell proliferation. However, treatment with
isoprenaline resulted in a significant reduction in
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Figure 7 Influence of phenylephrine on cell pro-
liferation rate 3 months after completion of DMH
treatment; by quintiles. ***P<0.001 phenylephrine vs
control. (i)control; (CI)phenylephrine.
mitotic rate of DMH-treated colon, adenoma and
adenocarcinoma. In normal and DMH-treated
colon and in adenomas of sympathectomized mice,
treatment with isoprenaline reduced the rate of cell
proliferation. There was no significant change in
the mitotic rate of adenocarcinomas in sympa-
thectomized mice treated with isoprenaline.
Discussion
The initial findings in the present study confirm
earlier observations from numerous laboratories
regarding the expansion of the proliferative zone
within the crypts following DMH treatment
(Springer et al., 1970; Wiebecke et al., 1973; Lipkin,
1974; Deschner, 1978; Chang et al., 1979; Richards,
1981). They also show, somewhat surprisingly, that
the mitotic rate was higher in adenomas than in
carcinomas.
The main thrust of the study concerns the
response to various biogenic amines by pre-
neoplastic and neoplastic colonic epithelial cells and
it is clear that at least some cells in the carcinogen-
treated crypt, as well as those in adenomas and
carcinomas, differ markedly from normal colonic
crypt cells in this respect. In the normal crypt, cell
proliferation is increased by alpha2 adrenoceptor
activity and decreased by alpha1 and beta adreno-
ceptor activity (Kennedy et al., 1983). By contrast,
in the colonic carcinomas tested in this study, cell
proliferation was stimulated by adrenaline and by
phenylephrine apparently acting via an alpha1
adrenoceptor but was inhibited by metaraminol and
clonidine activating alpha2 adrenoceptors. Stimula-
tion of cell proliferation by alpha1-adrenoceptors
has also been reported for both fibroblasts and
endothelial cells in vitro (Sherline & Mascardo,
1984). These colonic carcinomas of mice thus
appear to differ from those induced by the same
carcinogen in rats and from naturally occurring
human colonic tumours propagated as xenografts
in immune-deprived mice, both of which appear to
be inhibited by adrenaline but stimulated by certain
other biogenic amines. (Tutton & Barkla, 1977;
Tutton & Steel, 1979). In mouse colonic adenomas
cell proliferation also appeared to be stimulated by
adrenaline, but in this case the mechanism did not
appear to involve either an alpha or a beta adreno-
ceptor. The possibility of a dopamine receptor, with
some cross-sensitivity to adrenaline mediating this
effect must be considered.
It is now well known that exposure to DMH
causes an increase in the rate of cell proliferation in
the basal portion of the crypts of Lieberkuhn where
cell proliferation normally occurs and an expansion
of the zone of proliferation into the upper region of
the crypts where cell proliferation is usually
minimal or absent. Two temporal phases can be
distinguished in the response of colonic crypt cells
to DMH (Tutton & Barkla, 1983). The first phase
inolves crypt cell death immediately following
DMH treatment and is followed by compensatory
hyperplasia (Chan et al., 1976; Richards, 1977;
Sunter et al., 1981). Early in the course of DMH
treatment this hyperplasia appears to be reversible
(Richards, 1981). The second phase occurs some
weeks or months after DMH treatment, and also
involves hyperplasia, but does not appear to involve
crypt cell death and is not reversible. It is this
second phase that is associated with the appearance
of overt neoplasms (Springer et al., 1970; Wiebecke
et al., 1973; Lipkin 1974; Deschner 1978; Chang et
al., 1979; Richards 1981). It has been a tacit
assumption of most reports of these phenomena,
that the proliferating cells seen in the upper region
of the crypts following DNA treatment are the
abnormal or premalignant ones. However, it should
be noted that in the earlier reports concerning this
issue, the only observed functional attribute of a
cell in a particular location was its ability or
inability to divide: no information was available
regarding the factors controlling the cell. An
alternative interpretation of the response to
carcinogen treatment is that a group of abnormal
cells develop inhabiting the base of the crypts and
displace the more normal cells to an unusually
superficial region of the gland. Results in the
present study clearly support this alternative inter-
pretation in respect to the long term, but not jn
respect to the short term effects of DMH.
Analysis of our results suggests that, during the
early response to DMH cell proliferation is in-
fluenced by the same adrenergic mechanism as in
normal colon (Figure 8a). This is evidenced by theADRENERGIC FACTORS AND COLONIC CARCINOGENESIS 389
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Figure 8 Schematic representation of cell proliferation and adrenergic influences in the normal colonic crypt
(a), in the crypt shortly after DMH treatment (b) and three months after DMH treatment (c).
generally similar response to chemical sym-
pathectomy and alpha2 adrenoceptor blockade in
normal colon and in colon immediately following
DMH treatment. Whilst the zone of cell
proliferation was expanded at this stage, the
response of the proliferating cells to sympathectomy
and to adrenergic blockade remained normal
(Figure 8b). However, at a later stage after DMH
treatment, cells in the first, second and third
quintiles (counted from the base of the crypt)
respond to adrenergic manipulations in a manner
resembling the responses seen in tumours; that is, in
the second and third quintiles cell proliferation
increases following chemical sympathectomy, in the
second quintile alpha2 adrenoceptor blockade fails
to inhibit cell division, and in the first, second and
third quintiles alpha1 adrenoceptor stimulation
promotes cell division (Figure 8c). Note that even
at this late stage, the pharmacological responses
seen in the upper part of the abnormal crypt
resemble those seen in the lower part of the normal
crypt. Thus it would appear that, following carcino-
gen treatment, cells whose functional properties
relating to the regulation of cell proliferation
resemble neoplastic cells appear in the lower and
middle regions of the crypt whilst relatively normal
cells occupy the upper region of the crypt.
However, these relatively normal cells in the upper
region of the crypt are presumably derived by
migration of quasi-neoplastic cells in the lower
region. Hence, at this stage, a process of
maturation towards, rather than away from,
abnormal proliferative behaviour is occurring along
with migration. The onset of focal dysplasia and
overt neoplasia may then be associated with failure
of the cells to mature.
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